NCT03759860View on ClinicalTrials.gov

Laser (Selective Retina Therapy) and Drug Combined Intervention in Clinically Significant Diabetic Macular Edema

PHASE4UnknownINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 8, 2018

Primary Completion Date

July 30, 2019

Study Completion Date

July 30, 2020

Conditions
Diabetic Macular Edema
Interventions
COMBINATION_PRODUCT

R:GEN laser treatment (Selective Retina Therapy) and Lucentis (ranibizumab) combination therapy

Lucentis (ranibizumab) injection into the vitreous cavity after R:GEN laser treatment (Selective Retina Therapy)

Trial Locations (1)

Unknown

Hallym University Kangnam Sacred Heart Hospital, Seoul

Sponsors
All Listed Sponsors
lead

LUTRONIC Corporation

INDUSTRY